Key statistics
On Friday, Pharvaris NV (9EN:DUS) closed at 17.50, 29.63% above the 52 week low of 13.50 set on Nov 21, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 18.20 |
---|---|
High | 18.20 |
Low | 17.50 |
Bid | 15.60 |
Offer | 18.20 |
Previous close | 18.30 |
Average volume | 0.00 |
---|---|
Shares outstanding | 54.01m |
Free float | 32.77m |
P/E (TTM) | -- |
Market cap | 1.05bn USD |
EPS (TTM) | -2.67 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 18:30 BST.
More ▼
- Pharvaris Provides Business Update and Expands Development Program for Deucrictibant
- Pharvaris Presents Deucrictibant Long-Term Extension Data for Both the Prophylactic and On-Demand Treatment of HAE at the Bradykinin Symposium 2024
- Pharvaris Presents Data at the Bradykinin Symposium 2024
- Deucrictibant Clinical, Real-World, Nonclinical, and Discovery Data to be Presented at the Bradykinin Symposium
- Pharvaris Reports Second Quarter 2024 Financial Results and Provides Business Update
- Pharvaris Announces Annual Meeting of Shareholders
- Pharvaris Highlights Properties of Deucrictibant in Data Presentations at Recent Congresses
- Pharvaris to Present Clinical and Nonclinical Data at Upcoming Congresses
- Pharvaris Reports First Quarter 2024 Financial Results and Provides Business Update
- Pharvaris Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
More ▼